HOSPITAL UNIVERSITARIO RUBER
Departamento
Samsung Medical Center
Seúl, Corea del SurPublicaciones en colaboración con investigadores/as de Samsung Medical Center (3)
2023
-
Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial
JAMA Network Open, Vol. 6, Núm. 4, pp. E235822
2021
-
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
Annals of Oncology, Vol. 32, Núm. 2, pp. 197-207